Challenges of imaging interpretation to predict oligodendroglioma grade: a report from the Neuro-Oncology Branch

CNS Oncol. 2022 Mar 1;11(1):CNS83. doi: 10.2217/cns-2021-0005. Epub 2022 Feb 10.

Abstract

Background: To illustrate challenges of imaging interpretation in patients with oligodendroglioma seen at a referral center and evaluate interrater reliability. Methods: Two neuro-oncologists reviewed diagnostic preradiation MRIs of oligodendroglioma patients; interrater reliability was calculated with the kappa coefficient (k). A neuroradiologist measured presurgical apparent diffusion coefficient (ADC), if available. Results: Extensive enhancement was noted in four of 58 patients, k = 0.7; necrosis in seven of 58, k = 0.61; calcification in seven of 17, k = 1.0; diffusion restriction in two of 39 patients, k = 1.0 (all only in grade 3). ADC values with receiver operator characteristic analysis for area under the curve were 0.473, not significantly different from the null hypothesis (p = 0.14). Conclusions: Extensive enhancement, necrosis and calcification correlated with grade 3 oligodendroglioma in our sample. However, interrater variability is an important limitation when assessing radiographic features, supporting the need for standardization of imaging protocols and their interpretation.

Keywords: calcification; contrast enhancement; examiner concordance; interrater reliability; necrosis; oligodendroglioma; restricted diffusion.

MeSH terms

  • Brain Neoplasms* / diagnostic imaging
  • Diffusion Magnetic Resonance Imaging / methods
  • Humans
  • Neoplasm Grading
  • Oligodendroglioma* / diagnostic imaging
  • Reproducibility of Results
  • Retrospective Studies